Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT

Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT

Abstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this pro...

Full description

Bibliographic Details
Main Authors:	Jiale Hou, Tingting Long, Zhiyou He, Ming Zhou, Nengan Yang, Dengming Chen, Shan Zeng, Shuo Hu
Format:	Article
Language:	English
Published:	SpringerOpen 2021-06-01
Series:	EJNMMI Research
Online Access:	https://doi.org/10.1186/s13550-021-00797-4

Similar Items

Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
by: Panpan Zhang, et al.
Published: (2018-01-01)

Automated GMP compliant production of [18F]AlF-NOTA-octreotide
by: Térence Tshibangu, et al.
Published: (2020-01-01)

Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors
by: Babak Fallahi, et al.
Published: (2019-06-01)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
by: Abele, J., et al.
Published: (2022)

Comparison of 18F‐FDG PET/CT and 68Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia
by: Hao‐nan Yu, et al.
Published: (2021-05-01)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
by: Wolfgang G. Kunz, et al.
Published: (2018-09-01)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on 18F-FDG and 68Ga-DOTATATE PET
by: Gaia Ninatti, et al.
Published: (2020-12-01)

Efficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Halil Komek, et al.
Published: (2019-06-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma
by: Emily B. Ambinder, MD, et al.
Published: (2020-08-01)

Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
by: Mathias Loft, et al.
Published: (2021-02-01)

Molecular imaging of a glucagonoma with 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT imaging: A case report and review of the literature
by: Ahmed Fathala, MD, et al.
Published: (2020-01-01)

Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India
by: Julie Hephzibah, et al.
Published: (2014-09-01)

Phase equilibria in the LiF-AlF₃Na₃AlF₆ system
by: Stinton, David Paul
Published: (2016)

68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
by: Ronald Walker, et al.
Published: (2017-01-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

Phase equilibria in the LiF-AlF₃-Na₃AlF₆-Al₂O₃ system
by: Cassidy, Roger Thomas
Published: (2015)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
by: Paola Mapelli, et al.
Published: (2021-01-01)

Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.
by: Qinghua Liu, et al.
Published: (2015-01-01)

Impact of PET data driven respiratory motion correction and BSREM reconstruction of 68Ga-DOTATATE PET/CT for differentiating neuroendocrine tumors (NET) and intrapancreatic accessory spleens (IPAS)
by: Virginia Liberini, et al.
Published: (2021-01-01)

Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model.
by: Ning Guo, et al.
Published: (2012-01-01)

68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
by: Tessel M. Boertien, et al.
Published: (2020-02-01)

Somatostatin receptor scintigraphy with <sup>68</sup>Ga-DOTATATE PET/CT: initial experience in Cuba
by: Juan P. Oliva González
Published: (2017-06-01)

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
by: Pezhman Shahrokhi, et al.
Published: (2020-01-01)

Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
by: Barbara Zollner, et al.
Published: (2018-06-01)

Incidental Finding of Squamous Cell Carcinoma on a 68Ga-DOTATATE PET Scan
by: Sanjana Mullangi MD, et al.
Published: (2021-07-01)

Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [68Ga]Ga- and [18F]AlF-NOTA-Siglec-9
by: Olli Moisio, et al.
Published: (2018-01-01)

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
by: Schreiter Nils Friedemann, et al.
Published: (2014-12-01)

Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
by: Dale O. Kiesewetter, Ning Guo, Jinxia Guo, Haokao Gao, Lei Zhu, Ying Ma, Gang Niu, Xiaoyuan Chen
Published: (2012-01-01)

Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (18F-fluorodeoxyglucose and68Ga-DOTATATE) correlates and their treatment implications
by: Sarvesh Loharkar, et al.
Published: (2021-01-01)

68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas
by: Emily S. Kowalski, et al.
Published: (2021-08-01)

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
by: Luigi Aloj, et al.
Published: (2021-01-01)

Liquidus surface for the high cryolite/low alumina portion of the Na₃AlF₆-AlF₃-CaF₂-Al₂O₃ system
by: Xu, Ming-Wei Paul
Published: (2020)

FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient
by: Xiao Jiang, et al.
Published: (2021-03-01)

The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report
by: Karine A. Al Feghali, et al.
Published: (2018-10-01)

Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network
by: Jonathan Wehrend, et al.
Published: (2021-10-01)

Liquidus temperatures of Na3AlF6-AlF3-CaF2-KF-LiF-Al2O3 melts
by: Peng J.P., et al.
Published: (2014-01-01)

Gallium‐68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience
by: Alireza Aslani, et al.
Published: (2014-10-01)

Biological Evaluation of [18F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
by: Liping Lin, et al.
Published: (2021-04-01)

Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE
by: Charlotte Atkinson, et al.
Published: (2021-08-01)